Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma
NCT00598104 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2016-03-04
Summary
This study will evaluate the safety and efficacy of QAX576 against asthma attacks in adults with moderate persistent allergic asthma
Conditions
Interventions
- DRUG
-
QAX576
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
NOVARTIS · Novartis investigative site
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2008-12-31
More Related Trials
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma
NCT01568762 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
NCT01479595 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
NCT03707678 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
NCT02555683 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids
NCT04643158 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
NCT02563067 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
NCT06020014 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
NCT03226392 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients
NCT00814216 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
NCT05763121 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma
NCT01545726 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
NCT04946318 ·Status: TERMINATED ·Phase: PHASE2
-
A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
NCT03562949 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
NCT01478360 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma
NCT00946569 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RO5036505 in Patients With Moderate to Severe Asthma
NCT00967590 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
NCT01823016 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
NCT03215758 ·Status: COMPLETED ·Phase: PHASE3
-
Repeated High-dose Inhaled Corticosteroids for Asthma
NCT00695604 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
NCT01000506 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma
NCT01493882 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
NCT00983658 ·Status: COMPLETED ·Phase: PHASE2